From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference, the world's largest and most informative cooperation, exchange, and investment conference in the healthcare industry, will grandly open in San Francisco, USA.
During the conference, Beijing Youngen Biotechnology Co., Ltd. (referred to as "Youngen Biotechnology") will showcase its independently developed cardiac-targeted delivery technology KARDIASHUTTLETM and other innovative platforms at the "2026 China FIC Innovation and Cooperation Summit", demonstrating China's innovative strength and technological breakthroughs in the field of oligonucleotide drugs and targeted delivery technology to global investors and professionals.
2026 China FIC Innovation and Cooperation Summit
Organizer: ZFIC Alliance
Date: January 11, 2026
Venue: Hyatt Regency San Francisco Downtown, California, USA
Keynote Speech：
Highlights of China’s innovation in Oligonucleotide Innovative Drugs
Beijing Youngen Biotechnology Co., Ltd.
Youngen Biotechnology looks forward to discussing innovation with global industry partners in San Francisco and bringing China's original technologies to benefit patients around the world!
